{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T11:24:04Z","timestamp":1649157844904},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,6,13]],"date-time":"2007-06-13T00:00:00Z","timestamp":1181692800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Anaesthesist"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1007\/s00101-007-1218-5","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T05:26:54Z","timestamp":1181626014000},"page":"923-929","source":"Crossref","is-referenced-by-count":6,"title":["Maligne Hyperthermie"],"prefix":"10.1007","volume":"56","author":[{"given":"H.","family":"R\u00fcffert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Deutrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Olthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,6,13]]},"reference":[{"key":"1218_CR1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jmg.30.2.89","volume":"30","author":"Ball","year":"1993","unstructured":"Ball SP, Johnson KJ (1993) The genetics of malignant hyperthermia. J Med Genet 30: 89\u201393","journal-title":"J Med Genet"},{"key":"1218_CR2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.bbrc.2004.08.029","volume":"322","author":"Brini","year":"2004","unstructured":"Brini M (2004) Ryanodine receptor defects in muscle genetic diseases. Biochem Biophys Res Commun 322: 1245\u20131255","journal-title":"Biochem Biophys Res Commun"},{"key":"1218_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(60)92690-8","volume":"2","author":"Denborough","year":"1960","unstructured":"Denborough MA, Lovell RRH (1960) Anaesthetic deaths in a family. Lancet 2: 45","journal-title":"Lancet"},{"key":"1218_CR4","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/bmj.1.5848.272","volume":"1","author":"Denborough","year":"1973","unstructured":"Denborough MA, Dennett X, Anderson RM (1973) Central-core disease and malignant hyperpyrexia. BMJ 1: 272\u2013273","journal-title":"BMJ"},{"key":"1218_CR5","first-page":"50","volume":"43","author":"Deutsche","year":"2002","unstructured":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (2002) Leitlinien zur Therapie der malignen Hyperthermie. Anaesthesiol Intensivmed 43: 50\u201354","journal-title":"Anaesthesiol Intensivmed"},{"key":"1218_CR6","first-page":"831","volume":"43","author":"Deutsche","year":"2002","unstructured":"Deutsche Gesellschaft f\u00fcr An\u00e4sthesiologie und Intensivmedizin (2002) Verwendung von Succinylcholin. Anaesthesiol Intensivmed 43: 831","journal-title":"Anaesthesiol Intensivmed"},{"key":"1218_CR7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000542-200311000-00020","volume":"99","author":"Fiege","year":"2003","unstructured":"Fiege M, Wappler F, Weisshorn R et al. (2003) Induction of malignant hyperthermia in susceptible swine by 3,4-methylenedioxymethamphetamine (\u201eecstasy\u201c). Anesthesiology 99: 1132\u20131136","journal-title":"Anesthesiology"},{"key":"1218_CR8","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00000542-200405000-00008","volume":"100","author":"Girard","year":"2004","unstructured":"Girard T, Treves S, Voronkov A et al. (2004) Molecular genetic testing for malignant hyperthermia susceptibility. Anesthesiology 100: 1076\u20131080","journal-title":"Anesthesiology"},{"key":"1218_CR9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/humu.1203","volume":"18","author":"Girard","year":"2001","unstructured":"Girard T, Urwyler A, Censier K et al. (2001) Genotype-phenotype comparison of the Swiss malignant hyperthermia population. Hum Mutat 18: 357\u2013358","journal-title":"Hum Mutat"},{"key":"1218_CR10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/bja\/88.5.700","volume":"88","author":"Grogan","year":"2002","unstructured":"Grogan H, Hopkins PM (2002) Heat stroke: implications for critical care and anaesthesia. Br J Anaesth 88: 700\u2013707","journal-title":"Br J Anaesth"},{"key":"1218_CR11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/00008480-200404000-00018","volume":"16","author":"Halloran","year":"2004","unstructured":"Halloran LL, Bernard DW (2004) Management of drug-induced hyperthermia. Curr Opin Pediatr 16: 211\u2013215","journal-title":"Curr Opin Pediatr"},{"key":"1218_CR12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/bja\/85.1.118","volume":"85","author":"Hopkins","year":"2000","unstructured":"Hopkins PM (2000) Malignant hyperthermia: advances in clinical management and diagnosis. Br J Anaesth 85: 118\u2013128","journal-title":"Br J Anaesth"},{"key":"1218_CR13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2044.2004.03658.x","volume":"59","author":"Krause","year":"2004","unstructured":"Krause T, Gerbershagen MU, Fiege M et al. (2004) Dantrolene \u2013 A review of its pharmacology, therapeutic use and new developments. Anaesthesia 59: 364\u2013373","journal-title":"Anaesthesia"},{"key":"1218_CR14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/00000542-198706000-00012","volume":"66","author":"Larach","year":"1987","unstructured":"Larach MG, Rosenberg H, Larach DR, Broennle AM (1987) Prediction of malignant hyperthermia susceptibility by clinical signs. Anesthesiology 66: 547\u2013550","journal-title":"Anesthesiology"},{"key":"1218_CR15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00000433-198607030-00012","volume":"7","author":"Loghmanee","year":"1986","unstructured":"Loghmanee F, Tobak M (1986) Fatal malignant hyperthermia associated with recreational cocaine and ethanol abuse. Am J Forensic Med Pathol 7: 246\u2013248","journal-title":"Am J Forensic Med Pathol"},{"key":"1218_CR16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archneur.61.1.27","volume":"61","author":"Mathews","year":"2004","unstructured":"Mathews KD (2004) Multiminicore myopathy, central core disease, malignant hyperthermia susceptibility, and RYR1 mutations: one disease with many faces? Arch Neurol 61: 27\u201329","journal-title":"Arch Neurol"},{"key":"1218_CR17","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D","volume":"15","author":"McCarthy","year":"2000","unstructured":"McCarthy TV, Quane KA, Lynch PJ (2000) Ryanodine receptor mutations in malignant hyperthermia and central core disease. Hum Mutat 15: 410\u2013417","journal-title":"Hum Mutat"},{"key":"1218_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/15563658708992619","volume":"25","author":"Merigian","year":"1987","unstructured":"Merigian KS, Roberts JR (1987) Cocaine intoxication: hyperpyrexia, rhabdomyolysis and acute renal failure. J Toxicol Clin Toxicol 25: 135\u2013148","journal-title":"J Toxicol Clin Toxicol"},{"key":"1218_CR19","first-page":"398","volume":"52","author":"Mulley","year":"1993","unstructured":"Mulley JC, Kozman HM, Phillips HA (1993) Refined genetic localization for central core disease. Am J Hum Genet 52: 398\u2013405","journal-title":"Am J Hum Genet"},{"key":"1218_CR20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2174\/1566524023362429","volume":"2","author":"Nelson","year":"2002","unstructured":"Nelson TE (2002) Malignant hyperthermia: a pharmacogenetic disease of Ca++ regutating proteins. Curr Mol Med 2: 247\u2013269","journal-title":"Curr Mol Med"},{"key":"1218_CR21","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1007\/s001010050509","volume":"46","author":"Olthoff","year":"1997","unstructured":"Olthoff D, Vonderlind C (1997 Anesthesia unrelated triggering of a fatal malignant hyperthermia crisis. Anaesthesist 46: 1076\u20131080","journal-title":"Anaesthesist"},{"key":"1218_CR22","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","volume":"41","author":"\u00d8rding","year":"1997","unstructured":"\u00d8rding H, Brancadoro V, Cozzolino S et al. (1997) In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group. Acta Anaesthesiol Scand 41: 955\u2013966","journal-title":"Acta Anaesthesiol Scand"},{"key":"1218_CR23","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/geno.1996.0238","volume":"34","author":"Phillips","year":"1996","unstructured":"Phillips MS, Fujii J, Khanna VK et al. (1996) The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene. Genomics 34: 4\u201341","journal-title":"Genomics"},{"key":"1218_CR24","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1034\/j.1399-6576.2002.460610.x","volume":"46","author":"Rueffert","year":"2002","unstructured":"Rueffert H, Olthoff D, Deutrich C et al. (2002) Mutation screening in the ryanodine receptor 1 gene (RYR1) in patients susceptible to malignant hyperthermia who show definite IVCT results: identification of three novel mutations. Acta Anaesthesiol Scand 46: 692\u2013698","journal-title":"Acta Anaesthesiol Scand"},{"key":"1218_CR25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1399-0004.2001.590306.x","volume":"59","author":"Stewart","year":"2001","unstructured":"Stewart SL, Hogan K, Rosenberg H, Fletcher JE (2001) Identification of the Arg1086His mutation in the alpha subunit of the voltage-dependent calcium channel (CACNA1S) in a North American family with malignant hyperthermia. Clin Genet 59: 178\u2013184","journal-title":"Clin Genet"},{"key":"1218_CR26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2044.1993.tb07072.x","volume":"48","author":"Tehan","year":"1993","unstructured":"Tehan B, Hardern R, Bodenham A (1993) Hyperthermia associated with 3,4-methylenedioxyethamphetamine (\u201eEve\u201d). Anaesthesia 48: 507\u2013510","journal-title":"Anaesthesia"},{"key":"1218_CR27","doi-asserted-by":"crossref","first-page":"26332","DOI":"10.1074\/jbc.272.42.26332","volume":"272","author":"Tong","year":"1997","unstructured":"Tong J, Oyamada H, Demaurex N et al. (1997) Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and\/or central core disease. J Biol Chem 272: 26332\u201326339","journal-title":"J Biol Chem"},{"key":"1218_CR28","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.nmd.2005.06.008","volume":"15","author":"Treves","year":"2005","unstructured":"Treves S, Anderson AA, Ducreaux S (2005) Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscul Disord 15: 577\u2013587","journal-title":"Neuromuscul Disord"},{"key":"1218_CR29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","volume":"86","author":"Urwyler","year":"2001","unstructured":"Urwyler A, Deufel T, McCarthy T, West S (2001) Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia. Br J Anaesth 86: 283\u2013287","journal-title":"Br J Anaesth"},{"key":"1218_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/109065703322537214","volume":"7","author":"Wehner","year":"2003","unstructured":"Wehner M, Rueffert H, Koenig F, Olthoff D (2003) Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala. Genet Test 7: 203\u2013211","journal-title":"Genet Test"}],"container-title":["Der Anaesthesist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-007-1218-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00101-007-1218-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00101-007-1218-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T22:56:58Z","timestamp":1558565818000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00101-007-1218-5"}},"subtitle":["The ugly"],"short-title":[],"issued":{"date-parts":[[2007,6,13]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s00101-007-1218-5","relation":{},"ISSN":["0003-2417","1432-055X"],"issn-type":[{"value":"0003-2417","type":"print"},{"value":"1432-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,13]]}}}